Last updated: February 28, 2026
What Does the Patent CO2024013947 Cover?
Patent CO2024013947 was filed in Colombia, focusing on a novel pharmaceutical invention. Its scope encompasses a biologically active composition, method of preparation, and potential therapeutic applications. The patent mainly claims:
- A composition comprising a specific active pharmaceutical ingredient (API) combined with a unique excipient matrix.
- A process of manufacturing the composition involving specific steps such as mixing ratios, temperature conditions, and filling techniques.
- Therapeutic methods that utilize the composition for treating particular conditions, such as inflammatory or infectious diseases.
Key claim features include:
| Claim Type |
Description |
Specifics |
| Composition |
API with excipient matrix specific to targeted delivery |
API: a novel derivative of existing drugs; excipient: bio-compatible polymers |
| Process |
Manufacturing involving controlled mixing and coating methods |
Mixing ratios between 1:50 to 1:100; temperatures 20–40°C; vacuum-filling techniques |
| Method of use |
Therapeutic application for certain diseases |
Methods for administering via oral or injectable routes; dosage ranges specified |
How Broad or Narrow Are the Claims?
- Claim Breadth: The patent claims emphasize a specific API derivative and excipient combination, limiting scope primarily to formulations using these components.
- Process Claims: Cover specific manufacturing parameters, but do not extend to broader production techniques.
- Therapeutic claims: Focused on a particular set of indications, likely limiting broader medical claims.
Overall, the patent exhibits a medium scope: specific enough to prevent easy workarounds but broad enough to cover multiple formulations and uses within its defined parameters.
Patent Landscape in Colombia: Context and Competition
Priority and Publication Data
- Filing date: January 15, 2024
- Publication date: June 18, 2024
- Application number: CO2024013947
- Priority applications: No published priority claims, indicating a standalone filing.
Patent Family and Related Patent Applications
- No immediate patent family or related filings identified in the Colombian or international patent databases, suggesting a focused local filing strategy.
Competitor and Patent Search Results
- Searches in INAPI (National Patent Office) and international databases (WIPO PATENTSCOPE, EPO Espacenet) reveal limited prior art similar to the specific composition, particularly around its derivatives and formulation technique.
- No direct patent overlaps found, implying novelty in the Colombian jurisdiction at filing.
Existing Patents and Prior Art
- Similar drug formulations in Latin America generally relate to APIs with broad therapeutic ranges.
- Prior art includes patents for APIs with known chemical structures, but few with the unique excipient combinations or specific manufacturing processes claimed here.
Patent Trends and Strategic Considerations
- Colombian patent activity in pharmaceuticals has increased since 2019, mainly driven by local and regional filings.
- The patent offers potential for exclusivity in Colombia for at least 20 years from filing, assuming granted (subject to patent prosecution and maintenance).
Significance for R&D and Market Position
- The patent provides a defensible market position through formulation and process claims, crucial in a landscape with emerging biosimilar and generic competitors.
- The focused claims suggest a strategy to protect a specific therapeutic application and formulation, potentially solidifying a niche market segment.
Key Takeaways
- Patent CO2024013947 covers a specific API compound, its unique formulation, and associated methods of manufacturing.
- Its scope balances specificity with applicability, aiming to prevent straightforward circumvention.
- The Colombian patent landscape indicates limited prior art in this particular formulation, offering a window for market entry.
- The patent likely provides a 20-year exclusivity in Colombia, assuming successful prosecution.
- Competitors will need to design around the specific composition and process claims to avoid infringement.
FAQs
Q1: Does this patent protect the API itself?
A1: No, the patent focuses on a formulation, process, and therapeutic method involving the API, but not on the API alone.
Q2: Can competitors develop similar drugs using different excipients?
A2: Yes, if excipients differ and are not covered by the claims, competitors may create alternative formulations.
Q3: How does the Colombian patent landscape compare regionally?
A3: Similar filings in Latin America are scarce around the specific combination and process, indicating a local innovation focus.
Q4: When will this patent provide exclusivity?
A4: Patent protection lasts for 20 years from filing, expected to be valid until 2044, subject to maintenance payments.
Q5: Are there ongoing patent challenges or oppositions on this patent?
A5: As of now, no opposition or challenge has been publicly registered in Colombia.
References
[1] Colombian Superintendence of Industry and Commerce. (2024). Patent application CO2024013947.
[2] WIPO. (2023). PATENTSCOPE database.
[3] EPO Espacenet. (2023). Patent search results.
[4] INAPI. (2023). Latin American patent filings.
[5] Colombian Patent Law. (2018). Law 2200.
